Neurobiologic Mechanisms of Cognitive Dysfunction and Decline in Medulloblastoma
Neurobiologic Mechanisms of Cognitive Dysfunction and Decline in Medulloblastoma
批准号:
7898616
负责人:
SHELLI R KESLER
金额:
$16.3万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-08-01 至 2014-07-31
关键词:
Academic achievementAffectAgeAllelesArtsAttentionBehavior assessmentBehavioralBrainBrain InjuriesBrain NeoplasmsCatechol O-MethyltransferaseChildCognitiveCognitive deficitsCommon NeoplasmCorpus striatum structureCranial IrradiationDNADevelopmentDiagnosisDoseFamilyFamily dynamicsFemaleGenderGeneticGenotypeGoalsHippocampus (Brain)HumanImaging TechniquesImpaired cognitionImpairmentIndividualInterventionLifeLongevityMagnetic Resonance ImagingMalignant NeoplasmsMeasuresMedialMediatingMedicalMemoryNeoplasmsNeuroanatomyNeuropsychologyOutcomeParietalPathway interactionsPatientsPerformanceRadiationReadinessResearchResearch InfrastructureRiskSalivaSamplingSchoolsServicesSex CharacteristicsSocial WorkUniversitiesVisuospatialboysbrain volumecancer therapycancer typechemotherapydisabilityexecutive functiongenetic analysisgirlsmedical schoolsmedulloblastomaneurodevelopmentneuroimagingneuropsychologicaloncologyskillswhite matter
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): With the rising number of children who survive invasive brain tumors such as medulloblastoma (MB) which is the second most common tumor type, cognitive sequelae of these neoplasms and their treatments have begun to receive increased attention. This attention is particularly focused on the extensive, long-term disabilities that these cognitive impairments pose for patients and their families. Studies indicate that anti- cancer treatments (chemotherapy and cranial radiation) increase the risk for long-term cognitive deficits in children and that these impairments are often progressive. The prospect of intervening to change this trajectory thus has tremendous significance from a lifespan perspective - potentially affecting school services, family dynamics, vocational readiness and social services support. However, factors mediating the risk for cognitive impairments in children with MB or other types of cancer have not been adequately explored. The overarching aim of this project is to use advanced, multi-modal magnetic resonance imaging (MRI) techniques, focused genetic analyses and cognitive-behavioral assessment to elucidate the effects of MB and its treatments on functional neuroanatomy and cognitive-behavioral outcome. The specific aims are 1) to examine the neuroanatomical and neurofunctional substrates of cognitive impairment and decline in children with MB, 2) elucidate neurobiologic factors subserving gender differences in cognitive outcome among children with MB, and 3) determine the interaction of genetic, demographic and medical variables in predicting the cognitive trajectory of children with MB. Forty children with MB and 30 age and gender matched healthy controls age 3-14 years will undergo comprehensive neuropsychological and neuroimaging assessments at baseline and 12 months. Additionally, DNA will be extracted from saliva samples from all subjects and genotyped for catechol-O-methyltransferase (COMT) which is believed to influence cognitive outcome in individuals with brain injury. The ultimate goal of this research is to inspire the development of more specific and precise interventions, as well as to better understand when intervention is most needed and most effective. The research proposed here also will contribute more broadly to a better understanding. RELEVANCE : The ultimate goal of this research is to inspire the development of more specific and precise interventions for children with cancer, as well as to better understand when intervention is most needed and most effective. The research proposed here also will contribute more broadly to a better understanding of how early cancer- related brain injury affects brain development and neural organization in humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Using Connectomics and Machine Learning to Predict Survival in Diffuse Glioma
-
批准号:10289350
-
项目类别:
-
资助金额:$9.31万
-
财政年份:2021
-
负责人:SHELLI R KESLER
-
依托单位:
Predicting Long-Term Chemotherapy-Related Cognitive Impairment
-
批准号:10617793
-
项目类别:
-
资助金额:$50.05万
-
财政年份:2019
-
负责人:SHELLI R KESLER
-
依托单位:
Predicting Long-Term Chemotherapy-Related Cognitive Impairment
-
批准号:9899955
-
项目类别:
-
资助金额:$61.26万
-
财政年份:2019
-
负责人:SHELLI R KESLER
-
依托单位:
Predicting Long-Term Chemotherapy-Related Cognitive Impairment
-
批准号:10402797
-
项目类别:
-
资助金额:$53.53万
-
财政年份:2019
-
负责人:SHELLI R KESLER
-
依托单位:
Multimodal MRI Biomarker of Mild Cognitive Impairment in Breast Cancer
-
批准号:8690626
-
项目类别:
-
资助金额:$52.93万
-
财政年份:2012
-
负责人:SHELLI R KESLER
-
依托单位:
Prefrontal cortex abnormalities associated with breast cancer chemotherapy
-
批准号:8417775
-
项目类别:
-
资助金额:$32.58万
-
财政年份:2012
-
负责人:SHELLI R KESLER
-
依托单位:
Prefrontal cortex abnormalities associated with breast cancer chemotherapy
-
批准号:8551653
-
项目类别:
-
资助金额:$3.33万
-
财政年份:2012
-
负责人:SHELLI R KESLER
-
依托单位:
Multimodal MRI Biomarker of Mild Cognitive Impairment in Breast Cancer
-
批准号:8551730
-
项目类别:
-
资助金额:$51.33万
-
财政年份:2012
-
负责人:SHELLI R KESLER
-
依托单位:
Prefrontal cortex abnormalities associated with breast cancer chemotherapy
-
批准号:8712422
-
项目类别:
-
资助金额:$31.6万
-
财政年份:2012
-
负责人:SHELLI R KESLER
-
依托单位:
Multimodal MRI Biomarker of Mild Cognitive Impairment in Breast Cancer
-
批准号:9358338
-
项目类别:
-
资助金额:$39.52万
-
财政年份:2012
-
负责人:SHELLI R KESLER
-
依托单位:
Prefrontal cortex abnormalities associated with breast cancer chemotherapy
-
批准号:9024010
-
项目类别:
-
资助金额:$32.58万
-
财政年份:2012
-
负责人:SHELLI R KESLER
-
依托单位:
Multimodal MRI Biomarker of Mild Cognitive Impairment in Breast Cancer
-
批准号:8472125
-
项目类别:
-
资助金额:$55.06万
-
财政年份:2012
-
负责人:SHELLI R KESLER
-
依托单位:
TURNER SYNDROME: LINKING GENES, BRAIN AND BEHAVIOR
-
批准号:8169846
-
项目类别:
-
资助金额:$1.23万
-
财政年份:2010
-
负责人:SHELLI R KESLER
-
依托单位:
TURNER SYNDROME: LINKING GENES, BRAIN AND BEHAVIOR
-
批准号:7955372
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2009
-
负责人:SHELLI R KESLER
-
依托单位:
Neurobiologic Mechanisms of Cognitive Dysfunction and Decline in Medulloblastoma
-
批准号:8518258
-
项目类别:
-
资助金额:$16.68万
-
财政年份:2009
-
负责人:SHELLI R KESLER
-
依托单位:
Neurobiologic Mechanisms of Cognitive Dysfunction and Decline in Medulloblastoma
-
批准号:8098978
-
项目类别:
-
资助金额:$16.7万
-
财政年份:2009
-
负责人:SHELLI R KESLER
-
依托单位:
Neurobiologic Mechanisms of Cognitive Dysfunction and Decline in Medulloblastoma
-
批准号:8309325
-
项目类别:
-
资助金额:$16.69万
-
财政年份:2009
-
负责人:SHELLI R KESLER
-
依托单位:
Neurobiologic Mechanisms of Cognitive Dysfunction and Decline in Medulloblastoma
-
批准号:7658482
-
项目类别:
-
资助金额:$15.92万
-
财政年份:2009
-
负责人:SHELLI R KESLER
-
依托单位:
海外基金